Related references
Note: Only part of the references are listed.Antinuclear Antibody-Positive Patients Should Be Grouped as a Separate Category in the Classification of Juvenile Idiopathic Arthritis
Angelo Ravelli et al.
ARTHRITIS AND RHEUMATISM (2011)
Ongoing Disease Activity and Changing Categories in a Long-Term Nordic Cohort Study of Juvenile Idiopathic Arthritis
Ellen Nordal et al.
ARTHRITIS AND RHEUMATISM (2011)
Complete control of disease activity and remission induced by treatment with etanercept in juvenile idiopathic arthritis
Vera Papsdorf et al.
RHEUMATOLOGY (2011)
Juvenile idiopathic arthritis: state of the art and future perspectives
Alberto Martini et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Current therapeutic approaches to autoimmune chronic uveitis in children
Gabriele Simonini et al.
AUTOIMMUNITY REVIEWS (2010)
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register
F. H. M. Prince et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
Daniel J. Lovell et al.
ARTHRITIS AND RHEUMATISM (2008)
Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
Daniel J. Lovell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Development of a web-based register for the Dutch national study on biologicals in JIA: www.ABC-register.nl
F. H. M. Prince et al.
RHEUMATOLOGY (2008)
Juvenile idiopathic arthritis
Angelo Ravelli et al.
LANCET (2007)
The German etanercept registry for treatment of juvenile idiopathic arthritis
G Horneff et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Juvenile chronic arthritis into adulthood: a long-term follow-up study
M Zak et al.
RHEUMATOLOGY (2000)
Share Paper
